Cargando…

Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation

Objective: Appropriate use of oral anticoagulants (OACs) reduces the risk of stroke in patients with atrial fibrillation (AF). The study characterized the prescribing of OACs in people with AF in the Australian primary care setting over 10 years. Design: Retrospective population study. Setting and P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezabhe, Woldesellassie M., Bereznicki, Luke R., Radford, Jan, Wimmer, Barbara C., Curtain, Colin, Salahudeen, Mohammed S., Peterson, Gregory M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044929/ https://www.ncbi.nlm.nih.gov/pubmed/33867975 http://dx.doi.org/10.3389/fphar.2021.586370

Ejemplares similares

Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023)

Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What’s Your Beat?
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2022)

Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
por: Kefale, Adane Teshome, et al.
Publicado: (2022)

Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia
por: Zaidi, Anum Saqib, et al.
Publicado: (2022)

Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT)
por: Jatau Abubakar, Ibrahim, et al.
Publicado: (2020)

Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2019)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

Exploring Australian pharmacists’ perceptions and practices towards reducing the risk of medicines-related harm in aged care residents
por: Ali, Sheraz, et al.
Publicado: (2023)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol
por: Bezabhe, Woldesellassie M, et al.
Publicado: (2013)

Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Exploring Australian pharmacists' views toward reducing the risk of medicines‐related harm in aged care residents
por: Ali, Sheraz, et al.
Publicado: (2023)

Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2014)

The impact of partnered pharmacist medication charting in the emergency department on the use of potentially inappropriate medications in older people
por: Atey, Tesfay Mehari, et al.
Publicado: (2023)

Comparative Effectiveness and Safety of Low-Dose Oral Anticoagulants in Patients With Atrial Fibrillation
por: Perreault, Sylvie, et al.
Publicado: (2022)

Quality use of medicines in patients with chronic kidney disease
por: Castelino, Ronald L., et al.
Publicado: (2020)

Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
por: Armentaro, Giuseppe, et al.
Publicado: (2023)

Effectiveness and Safety of Oral Anticoagulants in Older Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Grymonprez, Maxim, et al.
Publicado: (2020)

Efficacy and safety of anticoagulation in atrial fibrillation patients with intracranial hemorrhage: A systematic review and meta-analysis
por: Zhou, Qiang, et al.
Publicado: (2023)

Prediction of Hospitalization due to Adverse Drug Reactions in Elderly Community-Dwelling Patients (The PADR-EC Score)
por: Parameswaran Nair, Nibu, et al.
Publicado: (2016)

Comparing Australian orthopaedic surgeons’ reported use of thromboprophylaxis following arthroplasty in 2012 and 2017
por: Mirkazemi, Corinne, et al.
Publicado: (2019)

Oral Anticoagulants Initiation in Patients with Atrial Fibrillation: Real-World Data from a Population-Based Cohort
por: Rodríguez-Bernal, Clara L., et al.
Publicado: (2017)

Efficacy and Safety of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and High Thromboembolic Risk. A Systematic Review
por: Acanfora, Domenico, et al.
Publicado: (2019)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

Major Bleeding Risk in Atrial Fibrillation Patients Co-Medicated With Non-Vitamin K Oral Anticoagulants and Antipsychotics
por: Chen, Chiung-Mei, et al.
Publicado: (2022)

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
por: Bezabih, Yihienew M., et al.
Publicado: (2021)

A Multilevel Analysis of Real-World Variations in Oral Anticoagulation Initiation for Atrial Fibrillation in Valencia, a European Region
por: García-Sempere, Aníbal, et al.
Publicado: (2017)

Anticoagulation in atrial fibrillation
por: Steinberg, Benjamin A, et al.
Publicado: (2014)

Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol
por: Holbrook, Anne, et al.
Publicado: (2016)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2022)

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia
por: Giner-Soriano, Maria, et al.
Publicado: (2023)

Community pharmacists’ knowledge and perspectives of reporting adverse drug reactions in Australia: a cross-sectional survey
por: Li, Raymond, et al.
Publicado: (2018)

Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based Consideration
por: Zhao, Shujuan, et al.
Publicado: (2020)

Adherence to Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Cross-National Comparison in Six European Countries (2008–2015)
por: Sabaté, M., et al.
Publicado: (2021)

An instrument to measure atrial fibrillation knowledge in Chinese patients: validation of the Jessa Atrial fibrillation Knowledge Questionnaire
por: Chang, Sijie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qkeb4m29ganjo89dcg2hoikl73